InspireMD, Inc. Files 8-K

Ticker: NSPR · Form: 8-K · Filed: Jul 1, 2024 · CIK: 1433607

Inspiremd, INC. 8-K Filing Summary
FieldDetail
CompanyInspiremd, INC. (NSPR)
Form Type8-K
Filed DateJul 1, 2024
Risk Levellow
Pages2
Reading Time3 min
Key Dollar Amounts$0.0001, $17.9 Million, $17.9 m, $16.9 million, $1.3827
Sentimentneutral

Sentiment: neutral

Topics: corporate-update, filing, financials

TL;DR

InspireMD filed an 8-K on July 1st, updating on corporate events and financials.

AI Summary

InspireMD, Inc. filed an 8-K on July 1, 2024, reporting on other events and financial statements. The company, incorporated in Delaware, is based in Tel Aviv, Israel, and operates in the surgical and medical instruments sector. This filing follows a name change from Saguaro Resources, Inc. on April 28, 2008.

Why It Matters

This 8-K filing provides an update on InspireMD, Inc.'s corporate activities and financial reporting, which is crucial for investors to stay informed about the company's status.

Risk Assessment

Risk Level: low — The filing is a routine 8-K for corporate updates and does not appear to contain significant new risks.

Key Numbers

Key Players & Entities

FAQ

What specific 'Other Events' are detailed in this 8-K filing?

The provided text does not specify the 'Other Events' but indicates that 'Other Events' is an item covered in the filing.

What is the primary business of InspireMD, Inc.?

InspireMD, Inc. operates in the 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS' sector, SIC code 3841.

When did InspireMD, Inc. change its name from Saguaro Resources, Inc.?

The company changed its name from Saguaro Resources, Inc. on April 28, 2008.

Where are InspireMD, Inc.'s principal executive offices located?

The principal executive offices are located at 4 Menorat Hamaor St., Tel Aviv, Israel, 6744832.

What is the fiscal year end for InspireMD, Inc.?

The fiscal year end for InspireMD, Inc. is December 31 (1231).

Filing Stats: 663 words · 3 min read · ~2 pages · Grade level 10.2 · Accepted 2024-07-01 07:00:16

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INSPIREMD, INC. Date: July 1, 2024 By: /s/ Craig Shore Name: Craig Shore Title: Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing